Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection

NCT00881517 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infection

Interventions

DRUG: HCMV-specific hyperimmune globulin (Cytotect®)
DRUG: Isotonic solution of sodium chloride (placebo)

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia